Registrations
Speakers
The Future of Personalized Medicine for Oncology, the one-day virtual summit is a conference where leading experts in oncology gather to discuss the latest advances and future directions in personalized medicine for cancer treatment. Personalized medicine is a medical approach that tailors treatment to an individual patient's specific genetic, environmental, and lifestyle factors to improve patient outcomes and reduce side effects. The summit will cover topics such as precision medicine, biomarkers, genomic profiling, immunotherapy, and other advanced technologies and approaches in oncology. Speakers will share experiences and insights on how personalized medicine is transforming cancer care and improving patient outcomes. All in all, "The Future of Personalized Medicine at the Oncology Virtual Summit" will be an exciting and informative event for anyone interested in the future of cancer treatment and the role of personalized medicine in transforming the field.
Precision medicine is a novel approach to cancer treatment that tailors treatment to the individual patient's specific genetic, environmental, and lifestyle factors. This allows for a more targeted and personalized approach to cancer treatment, taking into account the unique characteristics of each patient's cancer. This contrasts with the traditional "one size fits all" approach to cancer treatment, which may result in patients receiving ineffective treatment or causing unnecessary side effects. It has had a significant impact on cancer treatment, especially in the field of oncology. Advances in genomic profiling and other biomarker technologies have made it possible to identify specific genetic mutations and other molecular abnormalities that cause cancer in patients. This knowledge can lead to the development of targeted therapies that can directly address these anomalies, thereby improving treatment outcomes and patients' quality of life.
Advances in genomic profiling have revolutionized cancer treatment by providing a more personalized approach to patient care. Genomic profiling involves analyzing a patient's DNA to look for genetic mutations and other molecular abnormalities that allow cancer to grow and progress. This information is then used to develop targeted therapies specifically tailored to the unique characteristics of each patient's cancer. Recent advances in genomic profiling technology have enabled the rapid and accurate analysis of large amounts of genomic data. This has enabled the development of new biomarker tests that can identify specific genetic mutations and other molecular abnormalities associated with specific types of cancer. These tests are becoming more sophisticated and can provide more accurate information about a patient's cancer than ever before. As technology continues to advance, it will become an increasingly important tool in the fight against cancer.
Biomarkers are measurable indicators that can be used to detect the presence of a disease or predict its progression. In cancer diagnosis and treatment, biomarkers are important in determining the specific type of cancer and selecting the most appropriate treatment. Advances in biomarker research have resulted in new tools for cancer diagnosis and treatment that can significantly improve patient outcomes. In addition to liquid biopsies, many other novel biomarkers are being developed for cancer diagnosis and treatment. These include genetic and protein markers that can be used to predict which treatment will be most effective for a particular patient and markers that can be used to detect cancer at an earlier, more treatable stage.
Overall, the development of new biomarkers for cancer diagnosis and treatment is an exciting area of research that could significantly improve cancer treatment outcomes.
“ As a result of biomedical advances, we are facing the possibility of a future in which our humanity itself will be altered beyond recognition.” - Francis Fukuyama
Innovative keynotes delivered by the industry's true heavyweights, covering practical challenges and subjects which are exclusively entailed in our agenda. Gain subject matter expertise, network, and collaborate to explore solutions that shed light on future business models impacting revenue inflows.
Futurista Start-up Elevate is a dedicated platform for Startups and VCs. We offer industry-specific startups a showcasing opportunity, enabling them to connect with corresponding VCs and Mentors. A win-win dynamic is created to attain the desired exposure for startups who are looking forward to scaling up their businesses.
A smart application will help you connect with key decision makers, share files, brainstorm ideas, and have a seamless networking experience. A comprehensive module covering the entire event, compiled for training purposes, to be made available post-conference, exclusively for the attendees.
Digital medicine
Personalized health care technology
Mobile health (mHealth)
Digital Health
Wearables Technology
Targeted therapy
Evidence Based Medicine
Precision Oncology
Digital phenotyping
Genome targeted drugs
Computational genomics
Biochips
Digital Biomarker
Nutrigenomics
Value based pricing
Next Gen Sequencing
Microbiomics
DNA Database
CRISPR Cas9
Proteomics
Personalized Medical Devices
Biobanking
Companion Diagnostics
Nanomedicine
Electronic Health Record
Organ on chip
Telemedicine
DNA Profiling
Predictive Medicine
Preventive Medicine
Personalised Cancer Vaccine
Liquid Biopsy
Early Cancer Detection
mHealth
Digital Pathology
In Vitro Diagnostics
Pharmaceutical
Healthcare
Life Sciences & Biology
Biotechnology